Pharmaceutical discount agreements for Rasagiline (ATC N04BD02)
Pharmaceutical discount agreements for the active ingredient Rasagiline (ATC N04BD02): Conclusion of non-exclusive discount agreements under an Open House model with pharmaceutical companies. Uniform conditions apply without individual negotiations. The maximum contract duration is 24 months, with the earliest contract start on October 1, 2026. All contracts end at the latest 24 months after the earliest contract start. Entry is possible on the first of each month within the 24-month period. A right of termination exists with 6 weeks' notice to the end of the month. AOK Rheinland-Pfalz/Saarland reserves the right to replace the Open House contracts with exclusive discount agreements, which will automatically terminate the Open House contracts. For a contract start on October 1, 2026, documents must be submitted by August 31, 2026. For later contract starts, documents must be received by the end of the month preceding the desired start. This publication does not constitute a public contract within the meaning of Directive 2014/24/EU.
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 557385-2026HTML
- TED PDF — 557385-2026PDF
- TED XML — 557385-2026XML
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.